Yubo Wang

Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i> through Inhibition of IL-6 Signaling and EMT Reversal

Li Li, Rui Han, Hualiang Xiao et al. · Clinical Cancer Research · 2014 · 234 citations

Medicine, Oncology, Pharmacology +16

Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis

Zhongquan Zhao, Xiaoming Cheng, Yubo Wang et al. · PLoS ONE · 2014 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China

Yubo Wang, Yalan Qin, Ting Xie et al. · Clinical Infectious Diseases · 2020 · 99 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes

Hengyi Chen, Wenxiu Yao, Qian Chu et al. · Cancer Letters · 2015 · 93 citations

Medicine, Oncology, Pharmacology +8

Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway

Li Li, Wenting Huang, Kunlin Li et al. · Oncotarget · 2015 · 93 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15